NEW YORK ( TheStreet) -- WILEY JOHN & SONS (NYSE: JW.A) hit a new 52-week high Thursday as it traded at $49.40 compared with its previous 52-Week high of $49.00. WILEY JOHN & SONS is changing hands at $49.25 with 50,163 shares traded as of 12:10 p.m. ET. Average volume has been 142,900 shares over the past 30 days. WILEY JOHN & SONS has a market cap of $2.5 billion and is part of the services sector and media industry. Shares are up 7.4% year to date as of the close of trading on Wednesday. John Wiley & Sons, Inc., together with its subsidiaries, publishes print and electronic products that provide content and digital solutions to customers worldwide. The company has a P/E ratio of 17.3, equal to the average media industry P/E ratio and above the S&P 500 P/E ratio of 15.9. TheStreet Ratings rates WILEY JOHN & SONS as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, notable return on equity, growth in earnings per share and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full WILEY JOHN & SONS Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Markets
Replay: Jim Cramer on Earnings Season, China and Amazon Prime Day
Jim Cramer's breaking down what he expects from earnings season, China's slowing growth, and Amazon's Prime day sale.
Dow, S&P 500 and Nasdaq End at Record Closes as Earnings Season Kicks Off
All three stock indexes struggled to a record close Monday as investors gear up for earnings season.
Newt Gingrich on the U.S.-China Trade Talks, Biotech and Advice for Investors
Newt Gingrich weighs in on the U.S.-China trade deal, President Trump's social media presence, his focus on gene therapy and his advice for investors.
JPMorgan Is Bullish on the S&P 500's Second-Half Performance
JPMorgan raised its S&P price target to 3,200 from 3,000.